Live Quote · NASDAQAPGNHealthcare· Biotechnology

Apexigen, Inc.

$0.39 8.48%(+$0.03)
TickerSpark Score
53/100
Mixed
90
Valuation
40
Profitability
15
Growth
88
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APGN research report →

52-Week Range1% of range
Low
$0.33
Current
$0.39
High
$8.28
Company Overviewwww.apexigen.com

About the company

Apexigen Inc. , established in 2010 and based in San Carlos, California, is a clinical-stage biotechnology company dedicated to the discovery and advancement of antibody-based therapies for oncological diseases. The company's developmental pipeline features several promising candidates.

CEO
Xiaodong Yang
IPO
2021
Employees
11
HQ
San Carlos, CA, US

Price Chart

-92.06% · this period
$7.77$4.05$0.34Sep 01Mar 06Sep 01
Valuation
Market Cap
$9.57M
P/E
-0.24
P/S
0.00
P/B
1.19
EV/EBITDA
0.16
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
48.27%
ROIC
-493.64%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-31,452,000 · -8.92%
EPS
$-1.59 · -70.97%
Op Income
$-32,686,000
FCF YoY
-28.36%
Performance & Tape
52W High
$8.28
52W Low
$0.33
50D MA
$0.43
200D MA
$0.92
Beta
3.62
Avg Volume
262.33K

Get TickerSpark's AI analysis on APGN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Aug 23, 23Zabrowksi Dansell100,000
Aug 23, 23Wertheimer Samuel Psell1,845
Aug 23, 23Wertheimer Samuel Psell146,383
Aug 23, 23Wertheimer Samuel Psell100,000
Aug 23, 23Wertheimer Samuel Psell12,383
Aug 23, 23Smith Scott Andrewsell34,084
Aug 23, 23Smith Scott Andrewsell100,000
Aug 23, 23RINGOLD GORDONsell5,000
Aug 23, 23RINGOLD GORDONsell100,000
Aug 23, 23RINGOLD GORDONsell10,000
Coverage · APGN

Our APGN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on APGN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate APGN report →
Internal Compare

Similar companies

Peers in the same neighborhood.